LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
Clinical trial NCT01464086 · COMPLETED
Trial details
- NCT number
- NCT01464086
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-27
- Primary completion
- 2017-03-31
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.